Overview
This page focuses on how to think about basic dose and exposure concepts in an abstract way for GHRP-2 and similar peptides. It does not provide dosing instructions or protocols.
Key themes in dosing concepts
- Understanding vial amount, dilution volume, and resulting concentration.
- Relating concentration to an abstract "unit" or hypothetical dose.
- Recognizing that pharmacokinetics (absorption, distribution, metabolism, elimination) influence exposure beyond simple vial math.
Context and caveats
Any concrete dosing decisions for GHRP-2 must be grounded in product labelling (where it exists), formal clinical guidance, and individualized medical judgment. Educational tools such as calculators and half-life plotters are best treated as aids for understanding, not as dosing engines.
Sport & Anti-Doping Warning
GHRP-2 is an older growth hormone–releasing peptide that appears explicitly on the WADA Prohibited List and has been a target compound in laboratory detection research.
Modern anti-doping testing panels routinely include GHRP-2 and related peptides, so its use is risky even at what might seem like 'research' doses.